Professor, University of Manitoba
For the past 15 years, Geoff Hicks has focused on the development and application of high-throughput gene-trap and gene-targeting mutagenesis in mouse embryonic stem cells. He has been the Principal Investigator for several large-scale genomics grants awarded by the Canadian Institutes of Health Research (CIHR) and Genome Canada, and the recipient of a Canada Research Chair in Functional Genomics. More recently, his group developed new technologies to genetically engineer more direct models of human disease, including a flagship model of FASD. Hicks is also a founding member of the Canada-Israel International FASD Consortium and a PI in both the KBHN Network of Centres of Excellence and a CIHR New Team in the epigenetics of FASD. In 2009, he became the Director of the Regenerative Medicine Program at the University of Manitoba.
